Jean‐Frédéric Blanc
About
Jean‐Frédéric Blanc is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Jean‐Frédéric Blanc has authored 164 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 80 papers in Hepatology and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean‐Frédéric Blanc's work include Hepatocellular Carcinoma Treatment and Prognosis (75 papers), Pancreatic and Hepatic Oncology Research (41 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers). Jean‐Frédéric Blanc is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (75 papers), Pancreatic and Hepatic Oncology Research (41 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers). Jean‐Frédéric Blanc collaborates with scholars based in France, United States and Germany. Jean‐Frédéric Blanc's co-authors include Paulette Bioulac‐Sage, Jessica Zucman‐Rossi, Charles Balabaud, Gabrielle Couchy, Sandrine Imbeaud, Jean‐Charles Nault, Julien Caldéraro, Jean Saric, Éric Letouzé and António Sá Cunha and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.
In The Last Decade
Jean‐Frédéric Blanc
156 papers receiving 6.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jean‐Frédéric Blanc France | 41 | 2.9k | 2.0k | 1.8k | 1.8k | 1.4k | 164 | 6.8k | ||
| Kenichi Wakasa Japan | 40 | 2.2k 0.8× | 1.5k 0.7× | 1.2k 0.7× | 2.1k 1.2× | 808 0.6× | 260 | 6.5k | ||
| Sanjay Kakar United States | 52 | 1.5k 0.5× | 3.0k 1.5× | 1.5k 0.8× | 1.7k 1.0× | 1.1k 0.7× | 165 | 6.9k | ||
| Osamu Nakashima Japan | 46 | 4.6k 1.6× | 1.7k 0.9× | 976 0.5× | 2.9k 1.6× | 1.2k 0.8× | 204 | 7.5k | ||
| David J. Pinato United Kingdom | 38 | 2.2k 0.8× | 3.0k 1.5× | 1.3k 0.7× | 1.4k 0.8× | 1.3k 0.9× | 233 | 6.3k | ||
| Ronnie T. P. Poon Hong Kong | 54 | 4.5k 1.6× | 3.5k 1.7× | 3.0k 1.7× | 2.3k 1.3× | 2.2k 1.5× | 137 | 10.2k | ||
| Cheol Keun Park South Korea | 40 | 2.0k 0.7× | 1.5k 0.7× | 1.3k 0.7× | 1.4k 0.8× | 805 0.6× | 169 | 6.2k | ||
| Chiun Hsu Taiwan | 44 | 2.6k 0.9× | 3.2k 1.6× | 1.9k 1.1× | 1.5k 0.9× | 1.3k 0.9× | 226 | 7.4k | ||
| Lorenza Rimassa Italy | 42 | 2.7k 1.0× | 3.3k 1.6× | 1.3k 0.7× | 1.2k 0.7× | 1.2k 0.8× | 269 | 6.6k | ||
| Yutaka Takeda Japan | 38 | 1.3k 0.5× | 2.0k 1.0× | 1.5k 0.8× | 857 0.5× | 1.2k 0.8× | 311 | 5.3k | ||
| Iwao Ikai Japan | 54 | 6.6k 2.3× | 2.1k 1.1× | 1.7k 1.0× | 3.5k 2.0× | 1.4k 1.0× | 221 | 10.3k |
Countries citing papers authored by Jean‐Frédéric Blanc
Since
Specialization
Citations
This map shows the geographic impact of Jean‐Frédéric Blanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Frédéric Blanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Frédéric Blanc more than expected).
Fields of papers citing papers by Jean‐Frédéric Blanc
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jean‐Frédéric Blanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Frédéric Blanc. The network helps show where Jean‐Frédéric Blanc may publish in the future.
Co-authorship network of co-authors of Jean‐Frédéric Blanc
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Frédéric Blanc. A scholar is included among the top collaborators of Jean‐Frédéric Blanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Frédéric Blanc. Jean‐Frédéric Blanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Schneider, Carolin V., Aurélie Bèaufrere, Audrey Payancé, et al.. (2025). Alpha-1 antitrypsin deficiency and primary liver cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(2). 189290–189290.
2.
El-Khoueiry, Anthony B., Tae‐You Kim, Jean‐Frédéric Blanc, et al.. (2024). International, open-label phase 2 study of regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 42(16_suppl). 4007–4007.
3.
Merle, Philippe, Jean-Marie Péron, Karine Le Malicot, et al.. (2024). Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 42(16_suppl). e16195–e16195.
4.
Mathurin, Philippe, et al.. (2023). Treatment patterns, risk factors and outcomes for patients with newly diagnosed hepatocellular carcinoma in France: A retrospective database analysis. Clinics and Research in Hepatology and Gastroenterology. 47(5). 102124–102124.
5.
Blanc, Jean‐Frédéric, et al.. (2023). Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization. Pharmaceuticals. 16(12). 1676–1676.
6.
Di-Tommaso, Sylvaine, Jean‐William Dupuy, Nathalie Dugot‐Senant, et al.. (2023). Spatial characterisation of β-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim. JHEP Reports. 6(2). 100913–100913.
7.
Bayard, Quentin, Camille Péneau, Sandrine Imbeaud, et al.. (2022). Structure, Dynamics, and Impact of Replication Stress–Induced Structural Variants in Hepatocellular Carcinoma. Cancer Research. 82(8). 1470–1481.
8.
Rimassa, Lorenza, Robin Kate Kelley, Tim Meyer, et al.. (2021). Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma. Liver Cancer. 11(1). 38–47.
9.
Blanc, Jean‐Frédéric, Bruno Lapuyade, Panteleimon Papadopoulos, et al.. (2021). 18F-choline PET-computed tomography for the prediction of early treatment responses to transarterial radioembolization in patients with hepatocellular carcinoma. Nuclear Medicine Communications. 42(6). 633–638.
10.
Kelley, Robin Kate, Tim Meyer, Lorenza Rimassa, et al.. (2020). Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research. 26(18). 4795–4804.
11.
Bourdel‐Marchasson, Isabelle, C. Blanc-Bisson, A. Doussau, et al.. (2014). Nutritional Advice in Older Patients at Risk of Malnutrition during Treatment for Chemotherapy: A Two-Year Randomized Controlled Trial. PLoS ONE. 9(9). e108687–e108687.
12.
Hoppe, Stéphanie, M. Rainfray, Marianne Fonck, et al.. (2013). Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy. Journal of Clinical Oncology. 31(31). 3877–3882.
13.
Caldéraro, Julien, Jean‐Charles Nault, Paulette Bioulac‐Sage, et al.. (2013). ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 464(1). 53–60.
14.
Soubeyran, Pierre, Marianne Fonck, C. Blanc-Bisson, et al.. (2012). Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer. Journal of Clinical Oncology. 30(15). 1829–1834.
15.
Yi, Ping, Arisa Higa, Saı̈d Taouji, et al.. (2012). Sorafenib-Mediated Targeting of the AAA+ ATPase p97/VCP Leads to Disruption of the Secretory Pathway, Endoplasmic Reticulum Stress, and Hepatocellular Cancer Cell Death. Molecular Cancer Therapeutics. 11(12). 2610–2620.
16.
Galle, Peter R., Jean‐Frédéric Blanc, Jean‐Luc Van Laethem, et al.. (2008). 994 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND PRIOR ANTI-TUMOR THERAPY: A SUBANALYSIS FROM THE SHARP TRIAL. Journal of Hepatology. 48. S372–S372.
17.
Si‐Tayeb, Karim, Arnaud Monvoisin, Claire Mazzocco, et al.. (2006). Matrix Metalloproteinase 3 Is Present in the Cell Nucleus and Is Involved in Apoptosis. American Journal Of Pathology. 169(4). 1390–1401.
18.
Bioulac‐Sage, Paulette, Sandra Rebouissou, António Sá Cunha, et al.. (2005). Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver. Gastroenterology. 128(5). 1211–1218.
19.
Blanc, Jean‐Frédéric, Victor de Lédinghen, Pierre–Henri Bernard, et al.. (2000). Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. Journal of Hepatology. 32(5). 805–811.
20.
Blazejewski, Sylvie, Brigitte Le Bail, L. Boussarie, et al.. (1997). Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.. Europe PMC (PubMed Central). 151(3). 651–7.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kenichi Wakasa Breakdown of academic impact, for papers by Sanjay Kakar Breakdown of academic impact, for papers by Osamu Nakashima Breakdown of academic impact, for papers by David J. Pinato Breakdown of academic impact, for papers by Ronnie T. P. Poon Breakdown of academic impact, for papers by Cheol Keun Park Breakdown of academic impact, for papers by Chiun Hsu Breakdown of academic impact, for papers by Lorenza Rimassa Breakdown of academic impact, for papers by Yutaka Takeda Breakdown of academic impact, for papers by Iwao Ikai